roche pharmaceuticals (israel) ltd - valganciclovir 450 mg - film coated tablets - valganciclovir - valcyte is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prevention of cmv diseasein cmv-negative patients who have received a solid organ transplant from a cmv-positive donor.